Catalyst
Slingshot members are tracking this event:
Biohaven's Rimegepant in treating Migraine Phase 3 top-line data due 1Q 2018
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| BHVN |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 01, 2018
Occurred Source:
http://biohavenpharma.com/biohaven-announces-positive-results-from-bioequivalence-study-with-sublingual-rimegepant-zydis-orally-dissolving-tablet/
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Rimegepant, Migraine
